haygoodfoafyga1359.blogspot.com
May 12 /PRNewswire-FirstCall/ -- GE Healthcares (NYSE: GE) and Varian, Inc. (NasdaqGS: announce the availability ofthe MR901, a new pre-clinical 7T magnetifc resonance imaging (MRI) system which providese new capabilities for a broad range of research The Discovery MR901 combines GE Healthcare'ss state-of-the-art diagnostic technology with Varian's leading scientifixc platform to provide a pre-clinical MRI systen for the scientific community.
The pre-clinical technology aims to excek in soft tissue contrastand non-invasive techniques, includinv those used in research for metabolism, and physiology in research "Our offering provides a new level of depth and versatilityh to the scientific community," said , Vice Presidenyt and General Manager of Magnetic Resonance, GE Healthcare. "Thisd introduction provides the opportunity to strengthen our footprintf within clinical research while complementingv ourexisting portfolio." The range of preclinicap MRI applications includes brain and organ imaging, tumor disease progression and functional imaging.
Other potentialp research applications include investigation of new contrast mechanismand agents, monitoring gene expression, analysiws of protein interactions, and determinatio of pharmacokinetics. Varian and GE Healthcare announcef the Discovery MR901 at the International Societuy for Magnetic Resonance inMedicine (ISMRM) conference in Honolulu, The first unit is ready for shipment pendinyg completion of the customer "I am very pleased with how the syste integration has progressed. The first system is expected to ship this adding toour installed-base of leading MRI and NMR instrumentation, said , Vice President of Research Products at Varian.
For more technica information aboutVarian products, pleasre visit About Varian, Inc.: Inc. is a leading worldwide suppliedr of scientific instruments and vacuum technologiess for life science andindustrial applications. The compang provides complete solutions, including instruments, vacuum laboratory consumable supplies, software, training and support througg its global distribution andsupport systems. Inc. employs approximately 3,700 people worldwidse and operates manufacturing facilities inNortg America, Europe and Asia Varian, Inc. common stock is traded on the NASDAQa Global Select Market underthe symbol, "VARI." Furtherd information is available on the company's Web .
GE Healthcare provides transformational medical technologies and servicese that are shaping a new age ofpatieng care. Our expertise in medical imaging andinformationb technologies, medical diagnostics, patient monitoring systems, performancde improvement, drug discovery, and biopharmaceutical manufacturin g technologies is helping clinicians around the worlxd re-imagine new ways to diagnose, inform, treat and monitor disease, so patients can live theid lives to the fullest. GE Healthcare'x broad range of products and services enable healthcar e providers to better diagnose andtreat cancer, hear disease, neurological diseases and other conditionxs earlier.
Our vision for the future is to enable anew "early health" model of care focused on earlief diagnosis, pre- symptomatic disease detection and diseaser prevention. Headquartered in the United GE Healthcare isa $17 billion unit of General Electric Companh (NYSE: GE). Worldwide, GE Healthcar employs more than 46,000 people committed to servint healthcare professionals and their patients in more than100 countries. For more informatiob about GE Healthcare, visi our website at . For More Contact: Public Relations Varian, Inc. (925) 942-4702 pr@varianinc.com GE Healthcare, Wauwatosa Jennifer Francis (847) 277-4427 Jennifer.N.Francis@ge.com SOURCE Varian, Inc.
; GE Healthcars
No comments:
Post a Comment